Presentation was recorded on the Isagenix UK Roadshow in Birmingham UK on 03/31/17.
DSHEA Disclaimer
The statements (appearing on this Web site) have not been evaluated by the Food and Drug Administration. Isagenix products are not intended to diagnose, treat, cure or prevent any disease.
Weight-Loss Disclaimer
Weight loss should not be considered typical. In a study performed in 2012 by University of Illinois at Chicago researchers, subjects lost an average of 9 pounds with an average of 2 pounds of the loss from visceral fat after 30 days on an Isagenix system. The subjects also had a greater level of adherence and had more consistent weight loss from week to week compared to subjects on a traditional diet.
Safety Disclaimer
Note: If you are pregnant, nursing, diabetic, on medication, have a medical condition, or are beginning a weight control program, consult your physician before using Isagenix products or making any other dietary changes. Discontinue use if adverse events occur.
Information for General Purposes Only
Information provided on this Web site and on all publications, packaging, and labels is for general purposes only and designed to help you make informed decisions about your health. It is not intended to substitute advice from your physician or health-care professional.